The use of drones by the health care industry in Australia is one step closer to reality with the launch of the Angel Drones Trials by specialist remotely piloted aircraft system consulting company UAS International.
Dr Charlie Teo has been announced as the ambassador for the Angel Drones Trials and he will be giving a keynote address at the official launch, hosted by PwC at their Sydney CBD offices on 28 October 2016.
In an Australian first, a series of trials will commence later this year to determine the operational and economic feasibility of utilising drone technology to replace and/or supplement existing processes used for the delivery of various medical supplies. UAS International intends to also expand the trials eventually to include the passenger carrying drones with the potential for them to be used to transport medical professionals and/or patients to and from roadside trauma incidents’.
The Angel Drones Trials will put Australia drone technology at the forefront of health care innovation with a world-first collaboration between hospitals, health care leaders, drone manufacturers, drone operators and key stakeholders of the aviation community.
Similar initiatives have gained considerable media attention in recent months, namely a collaboration between US drone manufacturer Zipline and UPS, who have identified the considerable humanitarian benefits for such applications to be adopted in Rwanda, with plans to expand to other parts of Africa and in the United States.
UAS International, a majority-owned subsidiary of AvLaw, specialises in auditing and consulting services to the drone sector and has partnered with QBE insurance to develop an auditing standard against which commercial operators can be assessed against and which is playing a role in promoting responsible and safe use of drone technology beyond that which is required from the regulator.
If you are interested in attending the launch or would like to enquire with regards to any of UAS International’s services, please send an email to email@example.com or call (02) 9980 7792.Go back to all news